A detailed history of Mission Creek Capital Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 2,870 shares of LLY stock, worth $2.28 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
2,870
Previous 2,771 3.57%
Holding current value
$2.28 Million
Previous $2.51 Million 1.36%
% of portfolio
0.6%
Previous 0.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $76,441 - $95,041
99 Added 3.57%
2,870 $2.54 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $1.09 Million - $1.37 Million
1,510 Added 119.75%
2,771 $2.51 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $746,764 - $999,065
1,261 New
1,261 $981,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mission Creek Capital Partners, Inc. Portfolio

Follow Mission Creek Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.